| European Case Law Identifier: | ECLI:EP:BA:2002:G000399.20020218 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 18 February 2002 | ||||||||
| Case number: | G 0003/99 | ||||||||
| Referral: | T 0272/95 | ||||||||
| Application number: | 83307553.4 | ||||||||
| IPC class: | C12N 15/16 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | A | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Molecular cloning and characterization of a further gene sequence coding for human relaxin | ||||||||
| Applicant name: | Howard Florey Institute of Experimental Physiology & Medicine | ||||||||
| Opponent name: | (01) Aglietta, Amendola et al. (02) Paul Lannoye |
||||||||
| Board: | EBA | ||||||||
| Headnote: | 1. An opposition filed in common by two or more persons, which otherwise meets the requirements of Article 99 EPC and Rules 1 and 55 EPC, is admissible on payment of only one opposition fee. 2. If the opposing party consists of a plurality of persons, an appeal must be filed by the common representative under Rule 100 EPC. Where the appeal is filed by a non-entitled person, the Board of Appeal shall consider it not to be duly signed and consequently invite the common representative to sign it within a given time limit. The non-entitled person who filed the appeal shall be informed of this invitation. If the previous common representative is no longer participating in the proceedings, a new common representative shall be determined pursuant to Rule 100 EPC. 3. In order to safeguard the rights of the patent proprietor and in the interests of procedural efficiency, it has to be clear throughout the procedure who belongs to the group of common opponents or common appellants. If either a common opponent or appellant (including the common representative) intends to withdraw from the proceedings, the EPO shall be notified accordingly by the common representative or by a new common representative determined under Rule 100(1) EPC in order for the withdrawal to take effect. |
||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Admissibility - Fee for opposition - persons acting in common in filing notice of opposition - common opposition - joint opposition Admissibility - Fee for appeal - persons acting in common in filing notice of appeal - common appeal - joint appeal Common representative |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: | |||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/g990003ex1.html
Date retrieved: 17 May 2021
69 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.EPC Articles
EPC Implementing Rules
XR.84 EPC Continuation of the opposition proceedings by the European Patent Office of its own motion
EPO Guidelines - D Opposition and Limitation/Revocation Procedures
Offical Journal of the EPO
XOJ EPO SE 1/2021, p179 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2020)
XOJ EPO SE 1/2020, p174 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2019)
XOJ EPO SE 1/2019, p158 - XVI. - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2018)